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2019 Novel Coronavirus Overview
Dr. Anita Patel, PharmD
2019 Novel Coronavirus
 Much is unknown about 2019-nCoV
 Spreads from person-to-person and causes severe disease and 
death 
– Respiratory droplets by coughing or sneezing
– Close personal contact, such as touching or shaking hands
Situation Overview
 To date, 27 international locations (in addition to the U.S.) have 
reported confirmed cases of 2019-nCoV infection. 
 Two instances of person-to-person spread with this virus in the U.S. 
have been detected. 
– Both cases after close, prolonged contact with a returned 
traveler from Wuhan. 
 CDC established a 2019-nCoV Incident Management System on 
January 7, 2020. 
CDC Response
 Over the coming days and weeks, state and local public health departments 
will begin to test for 2019-nCoV in their laboratories. 
– Test results will be validated at CDC for a period of time, after which 
states will perform their own testing and report results to CDC. 
– CDC will continue to report case counts in aggregate. 
 While the immediate risk of this new virus to the American public is 
believed to be low at this time, everyone can do their part to help us 
respond to this emerging public health threat.
2019-nCoV: How Health Systems Can Prepare
Dr. Mike Bell, MD
Actions and Strategies to Stop Spread of 2019-nCoV
 The U.S. healthcare system responds to infectious disease threats every 
day. 
 CDC’s recommended actions and strategies to stop the spread of 2019-
nCoV are not new. They work and most are not reliant on PPE. 
– Established infection control strategies, consistent with standard 
precautions. 
 CDC’s goal—provide sound infection prevention control 
recommendations that protect healthcare workers AND are feasible and 
acceptable to implement. 
Strategies for Optimizing N95 Supply
Dr. Marie De Perio, MD 


Engineering Controls 
– Use of airborne infection 
isolation rooms (AIIR)
– Physical barriers such as 
glass/plastic windows
– Ventilation systems (clean-to-
contamination flow direction) 
Administrative Controls 
– Exclude HCP not directly 
involved in patient care
– Exclude visitors
– Source control
– Cohorting patients
– Cohorting HCP
– Just in time fit testing
Personal Protective Equipment (PPE)
– Define use of surgical N95 respirators
– Use of respirators that provide equivalent or higher protection
CDC Resources
 Interim Infection Prevention and Control Recommendations for Patients with 
Confirmed 2019 Novel Coronavirus (2019-nCoV) or Persons Under Investigation for 
2019-nCoV in Healthcare Settings 
– (https://go.usa.gov/xd9dY)   
 Healthcare Supply of Personal Protective Equipment
– (https://go.usa.gov/xd9pf)   
 Strategies for Optimizing the Supply of N95 Respirators
– (https://go.usa.gov/xd9pA)
 Considerations for Selection of Respirators in Healthcare
– (https://go.usa.gov/xd9pU)  
National Healthcare 
Organization 
Readiness Activities
National Healthcare Organization Readiness Activities
• Working collaborative with the CDC’s Health Pulse Program (key ED indicators)
• Clinical guidance distributed for Labor & Delivery and Maternal & Child Health 
screening workflows
• Patient management guidance provided for Home Health Care providers
• Training created for Medical Office Building strike teams
• HealthConnect (Epic) set up with patient screening questions
• Safety guidance distributed such as visitor and patient respiratory protection, 
airborne isolation precautions and disinfection procedures for rooms, equipment 
and PPE
• National Supply Chain Command Center active with twice daily calls 
• Monitoring all commercial manufacturing production 
• Supply conservation efforts implemented 
National Healthcare Organization Readiness Activities
• Exercises conducted to confirm facility readiness
• Prioritized early fit testing & training program distributed
• Partnering with waste management providers for safe handling of 
biohazardous and general waste
• New CoV information cascaded to all employees with reassurance to be 
concerned, but not panic
• Q&A distributed to all Member Service Contact Centers and Appointment 
and Advice Call Centers 
• Expedited responses sent to all employer group inquiries
• Monitoring and responding to social media posts 
• National HR policy published for potential employee exposure to 
coronavirus
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Initial Response
• Patient arrived at Providence Regional Medical Center in Everett, WA on 1/20/20
• “BEST” (Bio-containment Evaluation and Specialty Treatment) Team Initiated
Initial Response
• Initial PPE included:
• CAPR
• Impervious boot covers
• AAMI 4 level gown
• Double gloves (extended cuff)
• Hospital scrubs and shoes
“Right-Sized” Response
• AAMI 2 level gown
• Double gloves (regular)
• CAPR
• Usage estimates:
• 6 sets per shift when patient was feeling relatively well
• 20 sets per shift when patient was more symptomatic
System Response
How do we ensure appropriate response across different care 
settings?
Risk Assessment
• Coronavirus is primarily spread via droplet and contact routes
• Travel screen is in place:
• At all points of entry, allowing for early identification an isolation
• At scheduling, allowing patients to be directed to facilities that are 
prepared to respond
• In ambulatory care settings:
• Patients are identified and then transferred. No aerosol-generating 
procedures or testing is performed
• Most ambulatory cares settings do not have access to respirators
• Various health jurisdictions oversee the areas in which we provide care, each 
with different capacity and response time
• PPE is limited and anticipated to become more so
• CDC guidance for optimizing the supply of N95 respirators “Prioritize the use 
of N95 respirators for those HCP at the highest risk of acquiring infection”
Step 1: Travel Screen
Patient  arrives 
at facility
Earliest point of 
contact administers 
travel questionnaire
Patient Questions:
 Have you traveled to China in the last 30 days?
 Have you been in contact with someone who has traveled to China 
in the last 30 days who is now ill?
Yes to either
No to 
both
* Don’t know who this would be in 
your area?  Ask your manager.
If yes , travel screen is positive:
 Provide patient with mask
 Immediately contact clinical resource 
designated for your area* to proceed 
with symptom screen and triage.
 Clinical resource dons contact and 
droplet PPE (gloves, gown, and mask) 
for screening  
If no, 
Proceed with 
registration, 
check-in, triage  
or care.
Hospital-Based Setting Clinic-Based Setting
If yes , travel screen is positive:
 Provide patient with mask.
 Escort patient to room designated at your 
clinic for this purpose. 
 Immediately contact clinical resource 
designated for your area* to proceed 
with symptom screen and triage.  
All Settings
* Don’t know who this would be in your area?
Ask your manager.
Step 2: Symptom Screen
25
Use contact and airborne PPE and 
eye protection in addition to 
standard precautions
If not there already, move the 
patient to a negative pressure 
isolation room. If none available, 
use private room. 
Notify Nursing Supervisor 
immediately and ask that they 
reach Infection Control personnel. 
Notify local health authority.
If no symptoms 
identified, primary 
physician should 
consult with 
infection 
prevention and 
infectious disease 
to determine 
appropriate plan
Yes to any No to all
If positive travel 
screen, designated 
clinical resource dons 
PPE and escorts 
patient to isolation 
room to conduct 
symptom screen
 Fever above 100.4 F
 Cough, shortness of breath, or other lower respiratory symptoms
Does patient complain of or cite any of the following:
Hospital-Based Setting Clinic-Based Setting
Use contact and droplet PPE in 
addition to standard precautions.
Place patient in a private room with 
door closed (use negative pressure 
room if available)
Notify local health authority and 
regional lead.
Do not conduct testing or aerosol-
generating procedures on this patient 
without the express instruction of the 
local health department. 
Hospital-Based 
Settings
If no, 
 Proceed with 
registration, check-
in, triage  or care. 
 Provide patient 
with educational 
materials regarding 
symptoms of 
coronavirus and 
instructions on 
whom to contact if 
they become 
symptomatic
Clinic-Based Settings
PPE Update - Conservation
Type of Control Option Comments
Engineering Controls Immediately place patient in private room, 
preferably an AIIR
Use glass partitions at intake desks and triage 
stations
Administrative Controls Limit number of patients going to hospitals Use techniques with all isolation 
patients, not just PUI or 
confirmed coronavirus cases
Exclude HCP not directly involved in patient care
Limit face-to-face HCP encounters with patient
Exclude visitors
Provide facemasks for patient with symptoms
Cohort patients In the event of surge
Cohort healthcare personnel
Just-in-time fit testing
Telemedicine
Limiting respirators during training
PPE Update - Conservation
Type of Control Option Comments
PPE Control Use respirators after their intended shelf life Will hold onto expired 
respirators
Extend use: wearing the same N95 for repeated 
close contact encounters with several different 
patients, without removing the respirator 
between patient encounters. Extended use may 
be implemented when multiple patients are 
infected with the same respiratory pathogen 
and patients are placed together in dedicated 
waiting rooms or hospital wards
Could consider during surge
Reuse: refers to the practice of using the same 
N95 respirator by one HCP for multiple 
encounters with different patients but removing 
it after each encounter.  Only appropriate for 
diseases in which contact spread is not a 
concern.
Not an option for this pathogen, 
but could use for TB patients
Questions?
Email:
eocevent218@cdc.gov  
For more information, contact CDC
1-800-CDC-INFO (232-4636)
TTY:  1-888-232-6348    www.cdc.gov
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